Uncategorised - European Medical Journal

Continue
10 Mins
22 Mar 2022

Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy

The hypomethylating agents (HMA), azacitidine and decitabine, are currently regarded as the standard of care for patients with…
David Oliver
7 Mins
22 Mar 2022

Interview: David Oliver

David Oliver shared his thoughts with EMJ on his leadership and policy experience, his passion for advocacy in healthcare, and his work in…
EMJ 7.1 2022 Feature Image
5 Mins
22 Mar 2022

Science Versus COVID-19: What Have We Learnt So Far?

TWO YEARS AGO, the COVID-19 pandemic emerged and swept through the world, going on to have a profound human and health toll…
EMJ 7.1 2022 Feature Image
6 Mins
22 Mar 2022

Editor’s Pick: Thromboembolic Storm in the Recovering Stage of COVID-19: A Case Report

COVID 19 was first identified in late 2019 and led to a worldwide pandemic. Covid complications include thromboembolic storm…
EMJ 7.1 2022 Feature Image
10 Mins
22 Mar 2022

Utility of Evidence-Based Clinical Decision Support in Reducing Unwarranted Variations in Diagnosis and Treatment of Breast and Lung Cancer

It is clear that the delivery of advanced healthcare prolongs life. The global average life expectancy has almost doubled since 1900…
EMJ 7.1 2022 Feature Image
9 Mins
22 Mar 2022

ST Elevation Myocardial Infarction in Patients with COVID-19: Case Series

Patients with COVID 19 with associated myocardial infarction and myocarditis, requiring myocarditis treatment…
6 Mins
22 Mar 2022

Reactive Hip Arthritis and Avascular Necrosis After Severe COVID-19

Reactive arthritis is an emerging musculoskeletal manifestation post-COVID-19 infection. This is the first case reported of hip arthritis and avascular necrosis following the COVID-19 infection.
EMJ 7.1 2022 Feature Image
8 Mins
22 Mar 2022

Clinical Inertia of Discharge Planning Among Patients with Diabetes in Elhwari General Hospital

Diabetes is one of the most common chronic conditions. It affects a global population of approximately 425 million. The prevalence…
EMJ 7.1 2022 Feature Image
9 Mins
22 Mar 2022

The Impact of Intermediate Antidrug Antibodies to Infliximab and Adalimumab on Clinical Outcomes in Patients with Crohn’s Disease or Ulcerative Colitis

Anti-TNF drugs, adalimumab and infliximab are treatments for inflammatory bowel diseases (IBD), Chron’s disease, ulcerative colitis…
EMJ 7.1 2022 Feature Image
5 Mins
22 Mar 2022

Ewing’s Sarcoma of the Lung as a Second Malignancy in Long-Term Survivor of Childhood Hodgkin’s Lymphoma: A Rare Case Report and Literature Review

Long-term survivors of lymphoma frequently suffer relapses, such as Ewing’s sarcoma, following radiotherapy and chemotherapy…